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Could Central Hemodynamic Indices be the indicator of Orthostatic
Hypotension in Chinese Han Nationality population?
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OBJECTIVES Orthostatic hypotension (OH) is an independent risk
factor for cardiovascular morbidity. It is often unrecognized in the
elderly. Given the impact of OH, it would seem important to identify it
in clinical practice. The association between central hemodynamic
indices (e.g. central systolic blood pressure, augmentation index and
pulse wave velocity) and OH is unclear. This study evaluates whether
central hemodynamic indices are correlated with OH and tests the
usefulness of central hemodynamic indices to identifying OH.
METHODS A sample of 1099 participants was recruited from the
general population who attended health check-ups. Questionnaire,
physical examination and laboratory tests were performance by a
standard protocol. To assess the correlation between central hemo-
dynamic indices and the probability of OH, multiple logistic regres-
sion analysis was used to estimate the odds ratio in different models,
and the discriminatory power of hemodynamic indices for OH was
assessed by the area under the receiver operating curve (ROC).
RESULTS The prevalence of OH in this population was 5.6 %.
Compared with those without OH, OH subjects had a higher age, SBP
in sitting position, blood pressure in supine position, brachial-ankle
pulse wave velocity (BaPWV) and central systolic blood pressure
(CSBP) (all P< 0.05). After adjusting for potential confounders, both
CSBP (OR¼1.039, 95%CI: 1.016-1.062, P¼0.001) and BaPWV (OR¼1.259,
95%CI: 1.130-1.402, P<0.001) were signiﬁcantly positive correlated
with the probability of OH in a Chinese population. In addition,
BaPWV seemed to be a better discriminatory power than CSBP
(▵AUC¼ 0.128, 95% CI: 0.047-0.208, P¼0.002).
CONCLUSIONS BaPWV appeared to be a better indicator of OH than
CSBP in routine clinical practice. Future researches may be warranted
to assess whether this phenomenon still exists in a large population.
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OBJECTIVES Both bisoprolol and metoprolol sustained release tablet
(SR) are indicated in the management of hypertension. While long
duration of effect in metoprolol SR was achieved through its sus-
tained-release formulation, bisoprolol has intrinsic long duration of
action. This study aimed to investigate long action of bisoprolol
compared with metoprolol SR in controlling mean dynamic heart rate
and diastolic blood pressure in the last 4 hours of a 12-week treatment
period in patients with mild-to-moderate primary hypertension.
METHODS 186 mild-to-moderate hypertensive patients from 7 centers in
China were enrolled in this randomized, parallel, multicenter, open-label
clinical study from Dec 2011 to Dec 2014. Patients were treated with either
bispoprolol 5-10 mg or metoprolol SR 47.5-95 mg once daily for 12 weeks.
Primary end points were mean dynamic heart rate control and mean dy-
namic diastolic blood pressure control in the last 4 hours of the treatment
period. Secondary endpoints includedambulatorymonitoringof theblood
pressure and heart rate, safety, and compliance.
RESULTS A total of 186 subjects were enrolled and analyzed, 93
subjects in each group respectively. In the last 4 hours of the treat-
ment period, bisoprolol demonstrated signiﬁcantly better control of
mean dynamic heart rate compared with metoprolol SR (LSmeansdifference: –3.79 bpm,97.5% CI: –7.45, –0.14). In the last 4 hours of the
treatment period, the LSmeans difference of diastolic blood pressure
was –1.00 (97.5% CI: –4.79, 2.78), with the upper limit less than 4,
indicating that bisoprolol group was noninferior to metoprolol sus-
tained release tablets group bisoprolol further provided signiﬁcantly
better control in 24 hour mean ambulatory, mean daytime, and
nighttime heart rate. The overall adverse event (AE) rate was similar in
bisoprolol group and metoprolol SR group (20.43% vs 17.20%).
Noncompliance was reported in 3(3.53%) and 6(7.32%) subjects in
bisoprolol andmetoprolol sustained release tablets group respectively.
CONCLUSIONS Both bisoprolol and metoprolol SR could have long ac-
tion. Bisoprolol provided superior dynamic heart rate control and non-
inferior dynamic blood pressure control vs metoprolol SR in patients with
mild-to-moderate hypertension. No new safety concern was found.
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OBJECTIVES Nocturnal variations of blood pressure (BP) were asso-
ciated with type 2 diabetes. However, the relationship between the
reverse-dipper pattern of BP and type 2 diabetes remains unknown.
METHODS In this cross-sectional study, BP variations of 531 hyper-
tensive patients (285 men, 246 women) were evaluated with ambula-
tory blood pressure monitoring (ABPM). Circadian BP patterns were
then divided into dipper (10% to 20% SBP fall), nondipper (0% to 10%
SBP fall), extreme dipper (>20% SBP fall) and reverse dipper (SBP
nocturnal rise), according to the nocturnal reduction of systolic blood
pressure (SBP). All other hypertensive patients were excluded if they
(1) were <18 or >90 years old; (2) were under antihypertensive treat-
ment; (3) had a BP over 160/100 mmHg; (4) were night workers; (5) had
acute stroke or myocardial infarction within the past 6 months; (6) had
sleep apnea syndrome; (7) were diagnosed as secondary hypertension;
(8) could not tolerate the ABPM; (9) had other chronic diseases. Diag-
nosis of type 2 diabetes was made according to the 2015 Standards of
medical care in diabetes. Descriptive statistics are presented as per-
centages for discrete variables and as means (standard deviation) for
continuous variables. Multivariate logistic regression was used to
examine the relationship between type 2 diabetes and ABPM results.
RESULTS In our study, a total of 133 patients (21.0%) had reverse-
dipper BP pattern. Nondipper pattern was observed in 300 (47.5%)
hypertensive individuals and dipper pattern in 98 patients (15.5%).
Reverse dippers were older (P<0.05), while had a higher fasting glucose
(P<0.05), SBP- (P<0.05) and DBP-bedtime (P<0.05). Importantly, the
prevalence of diabetes (p<0.05) in reverse dippers was the highest
among the patients of all BP patterns. After analysis of multivariate
logistic regression, the reverse-dipper pattern of BP was shown to be
directly associated with type 2 diabetes (Odds ratio [OR] 1.630; 95%CI
1.057-2.512; p¼0.027). Moreover, fasting glucose was negatively corre-
lated with the decline rate of nocturnal SBP (r¼-0.128; p¼0.003) and
DBP (r¼-0.125; p¼0.004). The result of our study also suggested that
type 2 diabetes (OR 1.636; 95%CI 1.049-2.553; p¼0.030), age (OR 1.030;
95%CI 1.013-1.047; p¼0.030) and triglycerides (OR 1.247; 95%CI 1.010-
1.539; p¼0.040) might contribute to the reverse-dipper pattern of BP.
CONCLUSIONS The reverse-dipper pattern of BP in ABPM may serve
as one of the independent risk factors for type 2 diabetes. Therefore,
more personalized BP control should be administered on the patients
who had an elevated nocturnal BP.
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OBJECTIVES To investigate the plasma levels of migration inhibitory
factor(MIF) in hypertension-hyperlipidemia patients.
METHODS A total of 39 hypertension plus hyperlipidemia patients
without any previous treatment were enrolled(HTN-HLP). Twenty-ﬁve
